This article provides a comprehensive overview of the development of microbial cell factories (MCFs) for sustainable chemical and therapeutic production.
This article provides a comprehensive overview for researchers and drug development professionals on the synergistic fields of synthetic biology and metabolic engineering.
This article provides a comparative analysis of Mass Spectrometry (MS) and Nuclear Magnetic Resonance (NMR) spectroscopy for isotopic labeling studies, tailored for researchers and drug development professionals.
Accurately validating internal flux predictions is a critical challenge in Flux Balance Analysis (FBA), directly impacting its reliability in drug discovery, metabolic engineering, and systems biology.
This article provides a comprehensive comparative analysis of objective functions used in metabolic flux prediction, a critical task for researchers, scientists, and drug development professionals.
Accurate quantification of confidence intervals is crucial for interpreting metabolic flux estimates derived from stable isotope labeling experiments, yet the nonlinear nature of these systems presents significant statistical challenges.
This article provides a comprehensive framework for evaluating the robustness of Genome-Scale Metabolic Model (GSMM) reconstructions using 13C labeling data.
This article provides a comprehensive analysis for researchers and drug development professionals on the emerging paradigm of neural-mechanistic hybrid models and their benchmarking against traditional Flux Balance Analysis (FBA).
Metabolic reprogramming is a established hallmark of cancer, driving tumor progression and therapy resistance.
This article provides a comprehensive guide to goodness of fit (GOF) testing and model validation for 13C Metabolic Flux Analysis (13C-MFA), a gold-standard technique for quantifying intracellular reaction rates.